1. Neurobiology and neuropsychopharmacology of learning and memory, anxiety and other behavioral paradigms: The relationship between in vivo and in vitro drug effects and brain mechanisms. Identification and assessment of biochemical and molecular targets in neurotransmitter systems responsible for cognitive enhancement or decline.
2. Teratogenicity of ethanol, nicotine, caffeine and other stimulants, GHB, and gamma - ray irradiation.
3. Neurobiology of postnatal development and adolescence period. Identification and assessment of biochemical and molecular targets in neurotransmitter systems and growth factors involved in neuro damage effects after pharmacological manipulations with psychotropic drugs.
4. Pharmacology of cognitive enhancers and other drugs and substances that might promote recovery of cognitive function following brain damage.
5. Biochemistry and molecular biology of extrahepatic ethanol metabolism.
- Neurobiology and Neuropsychopharmacology of learning and memory, anxiety and other behavioral paradigms: The relationship between in vivo and in vitro drug effects and brain mechanisms. Identification and assessment of biochemical and molecular targets in neurotransmitter systems responsible for cognitive enhancement or decline.
- Teratogenicity of ethanol, nicotine, caffeine and other stimulants, GHB, and gamma - ray irradiation.
- Neurobiology of postnatal development and adolescence period. Identification and assessment of biochemical and molecular targets in neurotransmitter systems and growth factors involved in neuro damage effects after pharmacological manipulations with psychotropic drugs.
- Pharmacology of cognitive enhancers and other drugs and substances that might promote recovery of cognitive function following brain damage.
- Biochemistry and molecular biology of extrahepatic ethanol metabolism.
1. Neurobiology and neuropsychopharmacology of learning and memory, anxiety and other behavioral paradigms: The relationship between in vivo and in vitro drug effects and brain mechanisms. Identification and assessment of biochemical and molecular targets in neurotransmitter systems responsible for cognitive enhancement or decline.
2. Teratogenicity of ethanol, nicotine, caffeine and other stimulants, GHB, and gamma - ray irradiation.
3. Neurobiology of postnatal development and adolescence period. Identification and assessment of biochemical and molecular targets in neurotransmitter systems and growth factors involved in neuro damage effects after pharmacological manipulations with psychotropic drugs.
4. Pharmacology of cognitive enhancers and other drugs and substances that might promote recovery of cognitive function following brain damage.
5. Biochemistry and molecular biology of extrahepatic ethanol metabolism.
- Morphology of the brain and microscopic observation, in situ hybridization Dig-labeled methods for investigation of the availability of mRNA of alcohol dehydrogenase izozymes
- Western blotting methods for evaluation of the types subunits of receptors
Alcohol, Behavior Teratogenicity, Brain Functions, Drug of Abuse, Learning and Memory, Learning Enhancers, Nicotine, Prenatally Exposure
Pharmacetical production of drugs with profilaxe or cure effects against/on learning and memory disability in children with fetal alcohol, nicotine, X-ray effects
Nicotine receptor subtypes, learning and memory of offspring exposed pre- and posnatally to nicotine and ethanol together or separately, glutamat receptors - NMDA and AMPA
Drugs for amelioration of the learning and memory disability as result of behavioral teratogenicity of drug of abuse
Prenatally exposure of X-rays irradiation and brain abnormalities in the level of receptors and learning and memory
